43258 Federal Register / Vol. 86, No. 149 / Friday, August 6, 2021 / Notices 

through the use of appropriate 

automated collection techniques of 

other forms of information technology, 

e.g., permitting electronic submission of 

responses. 

Title: 0917–0014, ‘‘Indian Health 

Service Loan Repayment Program.’’ 

Type of Information Collection 

Request: Three year extension approval 

of this information collection. 

OMB Control Number: 0917–0014. 

Forms: Educational and Professional 

Background, Financial Information, and 

General Applicant Information (i.e., all 

forms are part of the LRP application). 

The LRP application is available in an 

electronically fillable and fileable 

format. 

Need and Use of Information 

Collection: The IHS LRP identifies 

health professionals with pre-existing 

financial obligations for education 

expenses that meet program criteria and 

who are qualified and willing to serve 

at, often remote, IHS health care 

facilities. Under the program, eligible 

health professionals sign a contract 

through which the IHS agrees to repay 

part or all of their indebtedness in 

exchange for an initial two-year service 

commitment to practice fulltime at an 

eligible Indian health program. This 

program is necessary to augment the 

critically low health professional staff at 

IHS health care facilities. 

Eligible health professionals wishing 

to have their health education loans 

repaid may apply to the IHS LRP. A 

two-year contract obligation is signed by 

both parties, and the individual agrees 

to work at an eligible Indian health 

program location and provide health 

services to American Indian and Alaska 

Native individuals. 

The information collected via the online application from individuals is 

analyzed and a score is given to each 

applicant. This score will determine 

which applicants will be awarded each 

fiscal year. The administrative scoring 

system assigns a score to the geographic 

location according to vacancy rates for 

that fiscal year and also considers 

whether the location is in an isolated 

area. When an applicant accepts 

employment at a location, the applicant 

in turn ‘‘picks-up’’ the score of that 

location. 

Status of the Proposed Information 

Collection: Renewal of a current 

collection. 

Affected Public: Individuals and 

households. 

Type of Respondents: Individuals. 

The table below provides: Types of 

data collection instruments, estimated 

number of respondents, Number of 

responses per respondent, annual 

number of responses, Average burden 

hour per response, and Total annual 

burden hour(s). 

ESTIMATED BURDEN HOURS

Data collection instrument(s) Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total annual 

responses 

(in hours) 

LRP Application ............................................................................................... 1,999 1 1.5 2,998.5 

LRP Application (3 forms in total) 

There are no Capital Costs, Operating 

Costs, and/or Maintenance Costs to 

report. 

Elizabeth A. Fowler, 

Acting Director, Indian Health Service. 

[FR Doc. 2021–16837 Filed 8–5–21; 8:45 am] 

BILLING CODE 4165–16–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request; Post-Award 

Reporting Requirements Including 

Research Performance Progress 

Report Collection (Office of the 

Director) 

AGENCY: National Institutes of Health, 

Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

National Institutes of Health (NIH) has 

submitted to the Office of Management 

and Budget (OMB) a request for review 

and approval of the information 

collection listed below. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 30-days of the date of this 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and 

instruments, contact: Ms. Mikia P. 

Currie, Program Analyst, Office of 

Policy for Extramural Research 

Administration, 6705 Rockledge Drive, 

Suite 350, Bethesda, Maryland 20892, or 

call a non-toll-free number 301–435– 

0941 or Email your request, including 

your address to 

ProjectClearanceBranch@mail.nih.gov. 

Formal requests for additional plans and 

instruments must be requested in 

writing. 

SUPPLEMENTARY INFORMATION: This 

proposed information collection was 

previously published in the Federal 

Register on April 12, 2021, pages 

18994–18995 (86 FR 18994) and 

allowed 60 days for public comment. No 

public comments were received. The 

purpose of this notice is to allow an 

additional 30 days for public comment. 

The Office of the Director (OD) Office of 

Policy and Extramural Research 

Administration (OPERA), National 

Institutes of Health, may not conduct or 

sponsor, and the respondent is not 

required to respond to, an information 

collection that has been extended, 

revised, or implemented on or after 

October 1, 1995, unless it displays a 

currently valid OMB control number. 

In compliance with Section 

3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. 

Proposed Collection: Public Health 

Service (PHS) Post-award Reporting 

Requirements Including Research 

Performance Progress Report Collection, 

Revision, OMB 0925–0002, Expiration 

Date 2/28/2023, Office of the Director 

(OD), National Institutes of Health 

(NIH). 

Need and Use of Information 

Collection: This collection is being 

revised to omit the Inclusion Enrollment 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 149 / Friday, August 6, 2021 / Notices 43259 

Report form, which is being converted 

to a Common form to include the 

Department of Defense (DoD). The 

Inclusion Enrollment Report is used for 

all applications involving NIH-defined 

clinical research. This form is used to 

report both planned and cumulative (or 

actual) enrollment, and describes the 

sex/gender, race, and ethnicity of the 

study participants. Starting in January 

2022, NIH will require will applicants 

and recipients to provide their Unique 

Entity Identifier (UEI) instead of the 

Data Universal Number System (DUNS) 

number. Also, the application forms 

will be updated to align with the 

Grants.gov updated Country and State 

lists. NIH also anticipates adding an 

optional field to the end of our forms 

and applications to get a more accurate 

assessment of the time it takes our 

applicants to complete the various 

forms and applications. The RPPR is 

required to be used by all NIH, Food 

and Drug Administration, Centers for 

Disease Control and Prevention, and 

Agency for Healthcare Research and 

Quality (AHRQ) grantees. Interim 

progress reports are required to continue 

support of a PHS grant for each budget 

year within a competitive segment. The 

phased transition to the RPPR required 

the maintenance of dual reporting 

processes for a period of time. 

Continued use of the PHS Noncompeting Continuation Progress Report 

(PHS 2590), exists for a small group of 

grantees. This collection also includes 

other PHS post-award reporting 

requirements: PHS 416–7 NRSA 

Termination Notice, PHS 2271 

Statement of Appointment, 6031–1 

NRSA Annual Payback Activities 

Certification, HHS 568 Final Invention 

Statement and Certification, iEdison, 

and PHS 3734 Statement Relinquishing 

Interests and Rights in a PHS Research 

Grant. The PHS 416–7, 2271, and 6031– 

1 is used by NRSA recipients to activate, 

terminate, and provide for payback of a 

NRSA. Closeout of an award requires a 

Final Invention Statement (HHS 568) 

and Final Progress Report. iEdison 

allows grantees and Federal agencies to 

meet statutory requirements for 

reporting inventions and patents. The 

PHS 3734 serves as the official record of 

grantee relinquishment of a PHS award 

when an award is transferred from one 

grantee institution to another. Pre-award 

reporting requirements are 

simultaneously consolidated under 

0925–0001 and the changes to the 

collection here are related. Clinical 

trials are complex and challenging 

research activities. Oversight systems 

and tools are critical for NIH to ensure 

participant safety, data integrity, and 

accountability of the use of public 

funds. NIH has been engaged in a multiyear effort to examine how clinical trials 

are supported and the level of oversight 

needed. The collection of more 

structured information in the PHS 

applications and pre-award reporting 

requirements as well as continued 

monitoring and update during the postaward reporting requirements will 

facilitate NIH’s oversight of clinical 

trials. In addition, some of the data 

reported in the RPPR will ultimately be 

accessible to investigators to update 

certain sections of forms when 

registering or reporting their trials with 

ClinicalTrials.gov. Frequency of 

response: Applicants may submit 

applications for published receipt dates. 

For NRSA awards, fellowships are 

activated, and trainees appointed. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

532,249. 

ESTIMATED ANNUALIZED BURDEN HOURS

Information collection forms Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total annual 

burden hours 

Reporting 

PHS 416–7 ...................................................................................................... 12,580 1 30/60 6,290 

PHS 6031–1 .................................................................................................... 1,778 1 20/60 593

PHS 568 .......................................................................................................... 11,180 1 5/60 932 

iEdison ............................................................................................................. 5,697 1 15/60 1,424 

PHS 2271 ........................................................................................................ 22,035 1 15/60 5,509 

PHS 2590 ........................................................................................................ 243 1 18 4,374 

RPPR—Core Data ........................................................................................... 32,098 1 8 256,784 

Biosketch (Part of RPPR) ................................................................................ 2,544 1 2 5,088 

Data Tables (Part of RPPR) ............................................................................ 758 1 4 3,032 

Trainee Diversity Report (Part of RPPR) ........................................................ 480 1 15/60 120 

PHS Human Subjects and Clinical Trial Information (Part of RPPR, includes 

inclusion enrollment report) .......................................................................... 6,420 1 4 25,680 

Publication Reporting ....................................................................................... 97,023 3 5/60 24,256 

Final RPPR—Core Data .................................................................................. 18,000 1 10 180,000 

Data Tables (Part of Final RPPR) ................................................................... 758 1 4 3,032 

Trainee Diversity Report (Part of Final RPPR) ............................................... 480 1 15/60 120 

PHS Human Subjects and Clinical Trial Information (Part of RPPR, includes 

inclusion enrollment report)) ........................................................................ 3,600 1 4 14,400 

PHS 374 .......................................................................................................... 479 1 30/60 240 

Reporting Burden Total ............................................................................ ........................ ........................ ........................ 531,874 

Recordkeeping 

SBIR/STTR Life Cycle Certification ................................................................. 1,500 1 15/60 375 

Grand Total ............................................................................................... 217,653 411,699 ........................ 532,249 


jbell on DSKJLSW7X2PROD with NOTICES
43260 Federal Register / Vol. 86, No. 149 / Friday, August 6, 2021 / Notices 

Dated: July 30, 2021. 

Lawrence A. Tabak, 

Principal Deputy Director, National Institutes 

of Health. 

[FR Doc. 2021–16849 Filed 8–5–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Insulin 

Resistance and Alzheimer’s Disease 

pathology. 

Date: September 3, 2021. 

Time: 1:30 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Video Meeting). 

Contact Person: Maurizio Grimaldi, MD, 

Ph.D., Scientific Review Officer, Scientific 

Review Branch, National Institute on Aging, 

National Institutes of Health, 7201 Wisconsin 

Avenue, Gateway Building, Suite 2W200, 

Bethesda, MD 20892, 301–496–9374, 

grimaldim2@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: August 2, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–16803 Filed 8–5–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Advancing 

Translational Sciences; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Advancing Translational Sciences Special 

Emphasis Panel; Rare Diseases. 

Date: September 14, 2021. 

Time: 11:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, 6701 Democracy Boulevard, Room 

1037, Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: Alumit Ishai, Ph.D., 

Scientific Review Officer, Office of Grants 

Management and Scientific Review, National 

Center for Advancing Translational Sciences, 

National Institutes of Health, 6701 

Democracy Boulevard, Room 1037, Bethesda, 

MD 20817, 301–827–5819, alumit.ishai@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.350, B—Cooperative 

Agreements; 93.859, Biomedical Research 

and Research Training, National Institutes of 

Health, HHS) 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–16866 Filed 8–5–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Eye Institute; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Eye Institute 

Special Emphasis Panel; Request for 

Proposals 75N98021R00006: Development, 

Statistical Design, Monitoring and 

Coordination of Vision Clinical Trials and 

Epidemiology Research. 

Date: August 30, 2021. 

Time: 1:00 p.m. to 3:30 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Eye Institute, National 

Institutes of Health, 6700B Rockledge Drive, 

Suite 3400, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Brian Hoshaw, Ph.D., 

Designated Federal Official, Division of 

Extramural Research, National Eye Institute, 

National Institutes of Health, 6700B 

Rockledge Drive, Suite 3400, Bethesda, MD 

20892, 301–451–2020, hoshawb@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.867, Vision Research, 

National Institutes of Health, HHS) 

Dated: August 3, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–16863 Filed 8–5–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOUSING AND 

URBAN DEVELOPMENT 

[Docket No. FR 6277–N–01] 

Fair Market Rents for the Housing 

Choice Voucher Program, Moderate 

Rehabilitation Single Room Occupancy 

Program, and Other Programs Fiscal 

Year 2022 

AGENCY: Office of the Assistant 

Secretary for Policy Development and 

Research, Housing and Urban 

Development (HUD). 

ACTION: Notice of Fiscal Year (FY) 2022 

Fair Market Rents (FMRs). 

SUMMARY: Section 8(c)(1) of the United 

States Housing Act of 1937 (USHA), as 

amended by the Housing Opportunities 

Through Modernization Act of 2016 

(HOTMA), requires the Secretary to 

publish FMRs not less than annually, 

adjusted to be effective on October 1 of 

each year. This notice describes the 


jbell on DSKJLSW7X2PROD with NOTICES